Skip to main content
Top
Published in: Drugs & Aging 8/2019

01-08-2019 | Hypertension | Therapy in Practice

Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients

Authors: Ian A. Scott, Sarah N. Hilmer, David G. Le Couteur

Published in: Drugs & Aging | Issue 8/2019

Login to get access

Abstract

Hypertension is commonly diagnosed in older patients, with increasing cardiovascular (CV) risk as systolic blood pressure (BP) increases. Maximising CV risk reduction must be reconciled with minimising the risk of treatment-related harms and burden, especially among frail, multi-morbid and older old patients who have been excluded from most randomised trials. Contemporary clinical guidelines, based on such trials, differ in their recommendations as to threshold levels warranting treatment with antihypertensive drugs (AHDs) and target levels that should be achieved. In optimising AHD prescribing in older patients, we propose the following decision framework: decide therapeutic goals in accordance with patient characteristics and preferences; estimate absolute CV risk; measure and profile BP accurately in ways that account for lability in BP levels and minimise error in BP measurement; determine threshold and target BP levels likely to confer net benefit, taking into account age, co-morbidities, frailty and cognitive function; and consider situations that warrant AHD deprescribing on the basis of potential current or future harm. In applying this framework to older persons, and based on a review of relevant randomised trials and observational studies, individuals most likely to benefit from treating systolic BP to no less than 130 mmHg are those of any age who are fit and have high baseline systolic BP (≥ 160 mmHg); high CV risk, i.e. established CV disease or risk of CV events exceeding 20% at 10 years; previous stroke or transient ischaemic attack; heart failure; and stage 3–4 chronic kidney disease with proteinuria. Individuals most likely to be harmed from treating BP to target systolic < 140 mmHg are those who have no CV disease and aged over 80 years; moderate to severe frailty, cognitive impairment or functional limitations; labile BP and/or history of orthostatic hypotension, syncope and falls; or life expectancy < 12 months. Treatment should never be so intense as to reduce diastolic BP to < 60 mmHg in any older person. At a time when guidelines are calling for less conservative management of hypertension in all age groups, we contend that a more temperate approach, such as that offered here and based on the totality of available evidence, may assist in maximising net benefit in older patients.
Literature
1.
go back to reference Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief. 2015;220:1–8. Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief. 2015;220:1–8.
2.
go back to reference Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014;130:820–8.CrossRefPubMedPubMedCentral Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014;130:820–8.CrossRefPubMedPubMedCentral
3.
go back to reference Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–15.CrossRefPubMed Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–15.CrossRefPubMed
4.
go back to reference Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al.; The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al.; The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104.
5.
go back to reference Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426–83.PubMed Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426–83.PubMed
6.
go back to reference Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA; Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166(6):430–437. Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA; Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166(6):430–437.
8.
go back to reference Padwal R, Rabi DM, Schiffrin EL. Recommendations for intensive blood pressure lowering in high-risk patients, the Canadian viewpoint. Hypertension. 2016;68:3–5.CrossRefPubMed Padwal R, Rabi DM, Schiffrin EL. Recommendations for intensive blood pressure lowering in high-risk patients, the Canadian viewpoint. Hypertension. 2016;68:3–5.CrossRefPubMed
9.
go back to reference Gabb GM, Mangoni A, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. Guidelines for the diagnosis and management of hypertension in adults—2016. Med J Aust. 2016;205:85–9.CrossRefPubMed Gabb GM, Mangoni A, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. Guidelines for the diagnosis and management of hypertension in adults—2016. Med J Aust. 2016;205:85–9.CrossRefPubMed
10.
go back to reference James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefPubMed James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefPubMed
11.
go back to reference Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26.CrossRef Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26.CrossRef
12.
go back to reference Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med. 2017;166(6):419–29.CrossRefPubMed Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med. 2017;166(6):419–29.CrossRefPubMed
13.
go back to reference Garrison SR, Kolber MR, Korownyk CS, McCracken RK, Heran BS, Allan GM. Blood pressure targets for hypertension in older adults. Cochrane Database Syst Rev 2017;8:CD011575. Garrison SR, Kolber MR, Korownyk CS, McCracken RK, Heran BS, Allan GM. Blood pressure targets for hypertension in older adults. Cochrane Database Syst Rev 2017;8:CD011575.
14.
go back to reference Briasoulis A, Agarwal V, Tousoulis D, et al. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100:317–23.CrossRefPubMed Briasoulis A, Agarwal V, Tousoulis D, et al. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100:317–23.CrossRefPubMed
15.
go back to reference Cao DX, Tran RJC. Considerations for optimal blood pressure goals in the elderly population: a review of emergent evidence. Pharmacotherapy. 2018;38(3):370–81.CrossRefPubMed Cao DX, Tran RJC. Considerations for optimal blood pressure goals in the elderly population: a review of emergent evidence. Pharmacotherapy. 2018;38(3):370–81.CrossRefPubMed
16.
go back to reference Materson BJ, Garcia-Estrada M, Preston RA. Hypertension in the frail elderly. J Am Soc Hypertens. 2016;10(6):536–41.CrossRefPubMed Materson BJ, Garcia-Estrada M, Preston RA. Hypertension in the frail elderly. J Am Soc Hypertens. 2016;10(6):536–41.CrossRefPubMed
17.
go back to reference Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e116–35.CrossRefPubMed Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e116–35.CrossRefPubMed
18.
go back to reference Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98.CrossRefPubMed Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98.CrossRefPubMed
19.
go back to reference Jacobs JM, Stessman J, Ein-Mor E, Bursztyn M. Hypertension and 5-year mortality among 85-year-olds: the Jerusalem Longitudinal Study. J Am Med Dir Assoc. 2012;13(8):759.e1–6.CrossRef Jacobs JM, Stessman J, Ein-Mor E, Bursztyn M. Hypertension and 5-year mortality among 85-year-olds: the Jerusalem Longitudinal Study. J Am Med Dir Assoc. 2012;13(8):759.e1–6.CrossRef
20.
go back to reference The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.CrossRefPubMedCentral The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.CrossRefPubMedCentral
21.
go back to reference Sexton DJ, Canney M, O’Connell MDL, Moore P, Little MA, O’Seaghdha CM, et al. Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med. 2017;177(9):1385–7.CrossRefPubMedPubMedCentral Sexton DJ, Canney M, O’Connell MDL, Moore P, Little MA, O’Seaghdha CM, et al. Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med. 2017;177(9):1385–7.CrossRefPubMedPubMedCentral
22.
go back to reference Touyz RM, Dominiczak AF. Successes of SPRINT, but still some hurdles to cross. Hypertension. 2016;67:268–9.CrossRefPubMed Touyz RM, Dominiczak AF. Successes of SPRINT, but still some hurdles to cross. Hypertension. 2016;67:268–9.CrossRefPubMed
24.
go back to reference Kuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative descriptive study on the alignment of care goals between older persons with multimorbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013;14:133.CrossRefPubMedPubMedCentral Kuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative descriptive study on the alignment of care goals between older persons with multimorbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013;14:133.CrossRefPubMedPubMedCentral
25.
go back to reference Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc. 2008;56(8):1409–16.CrossRefPubMedPubMedCentral Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc. 2008;56(8):1409–16.CrossRefPubMedPubMedCentral
26.
go back to reference Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279(11):839–46.CrossRefPubMed Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279(11):839–46.CrossRefPubMed
27.
go back to reference Padiyar A. Nonpharmacologic management of hypertension in the elderly. Clin Geriatr Med. 2009;25(2):213–9.CrossRefPubMed Padiyar A. Nonpharmacologic management of hypertension in the elderly. Clin Geriatr Med. 2009;25(2):213–9.CrossRefPubMed
28.
go back to reference Cook NR, Ridker PM. Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update. Ann Intern Med. 2016;165:786–94.CrossRefPubMed Cook NR, Ridker PM. Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update. Ann Intern Med. 2016;165:786–94.CrossRefPubMed
29.
go back to reference Cooney MT, Selmer R, Lindman A, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–1103. Cooney MT, Selmer R, Lindman A, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–1103.
30.
go back to reference Nelson M. Management of “hypertension” based on blood pressure level versus an absolute cardiovascular risk approach. Curr Hypertens Rep. 2019;21(1):6.CrossRefPubMed Nelson M. Management of “hypertension” based on blood pressure level versus an absolute cardiovascular risk approach. Curr Hypertens Rep. 2019;21(1):6.CrossRefPubMed
31.
go back to reference Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognising the problem and proposing the solution. Hypertension. 2010;55:195–200.CrossRefPubMed Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognising the problem and proposing the solution. Hypertension. 2010;55:195–200.CrossRefPubMed
32.
33.
go back to reference Kallionen N, Hill A, Horswill MS, Ward HE, Watson MO. Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421–41.CrossRef Kallionen N, Hill A, Horswill MS, Ward HE, Watson MO. Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421–41.CrossRef
34.
go back to reference Frith J, Newton JL, Parry SW. Measuring and defining orthostatic hypotension in the older person. Age Aging. 2014;43(2):168–70.CrossRef Frith J, Newton JL, Parry SW. Measuring and defining orthostatic hypotension in the older person. Age Aging. 2014;43(2):168–70.CrossRef
35.
go back to reference Scuteri A, Modestino A, Frattari A, Di Daniele N, Tesauro M. Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with? J Gerontol A Biol Sci Med Sci. 2012;67(7):804–10. Scuteri A, Modestino A, Frattari A, Di Daniele N, Tesauro M. Occurrence of hypotension in older participants. Which 24-hour ABPM parameter better correlate with? J Gerontol A Biol Sci Med Sci. 2012;67(7):804–10.
36.
go back to reference Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139–44. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139–44.
37.
go back to reference Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80? Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension. 2013;61(1):89–94.CrossRefPubMed Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80? Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension. 2013;61(1):89–94.CrossRefPubMed
38.
go back to reference Turgut F, Yesil Y, Balogun RA, Abdel-Rahman EM. Hypertension in the elderly: unique challenges and management. Clin Geriatr Med. 2013;29(3):593–609.CrossRefPubMed Turgut F, Yesil Y, Balogun RA, Abdel-Rahman EM. Hypertension in the elderly: unique challenges and management. Clin Geriatr Med. 2013;29(3):593–609.CrossRefPubMed
39.
go back to reference Sui AL, US Preventive Services Task Force. Screening for high blood pressure in adults: US Preventive Services Task Force statement. Ann Intern Med. 2015;163:778–86.CrossRef Sui AL, US Preventive Services Task Force. Screening for high blood pressure in adults: US Preventive Services Task Force statement. Ann Intern Med. 2015;163:778–86.CrossRef
40.
go back to reference Campbell PGNWD, Wolfson L, White WB. Long-term reproducibility of ambulatory blood pressure is superior to office pressure in the very elderly. J Hum Hypertens. 2010;24:749–54. Campbell PGNWD, Wolfson L, White WB. Long-term reproducibility of ambulatory blood pressure is superior to office pressure in the very elderly. J Hum Hypertens. 2010;24:749–54.
41.
go back to reference O’Sullivan C, Duggan J, Atkins N, et al. Twenty-four ambulatory blood pressure in community-dwelling elderly men and women, aged 60–102 years. J Hypertens. 2003;21:1641–7.CrossRefPubMed O’Sullivan C, Duggan J, Atkins N, et al. Twenty-four ambulatory blood pressure in community-dwelling elderly men and women, aged 60–102 years. J Hypertens. 2003;21:1641–7.CrossRefPubMed
42.
go back to reference Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the third health and nutrition examination survey, 1988–1991. Hypertension. 1995;25:305–313. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the third health and nutrition examination survey, 1988–1991. Hypertension. 1995;25:305–313.
43.
go back to reference Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123:719–26.CrossRefPubMedPubMedCentral Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123:719–26.CrossRefPubMedPubMedCentral
44.
go back to reference Rastas S, Pirttila T, Viramo P, Verkkoneimi A, Halonen P, Juva K, et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006;54:912–8.CrossRefPubMed Rastas S, Pirttila T, Viramo P, Verkkoneimi A, Halonen P, Juva K, et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006;54:912–8.CrossRefPubMed
45.
go back to reference Weidung B, Toots A, Nordström P, Carlberg B, Gustafson Y. Systolic blood pressure decline in very old individuals is explained by deteriorating health: longitudinal changes from Umeå85 +/GERDA. Medicine (Baltimore). 2017;96(51):e9161.CrossRefPubMedPubMedCentral Weidung B, Toots A, Nordström P, Carlberg B, Gustafson Y. Systolic blood pressure decline in very old individuals is explained by deteriorating health: longitudinal changes from Umeå85 +/GERDA. Medicine (Baltimore). 2017;96(51):e9161.CrossRefPubMedPubMedCentral
46.
go back to reference Merlo J, Ranstam J, Liedholm H, Hedblad B, Lindberg G, Lindblad U, et al. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ. 1996;313(7055):457–61.CrossRefPubMedPubMedCentral Merlo J, Ranstam J, Liedholm H, Hedblad B, Lindberg G, Lindblad U, et al. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ. 1996;313(7055):457–61.CrossRefPubMedPubMedCentral
47.
go back to reference Tervahauta M, Pekkanen J, Enlund H, Nissinen A. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens. 1994;12(10):1183–9.CrossRefPubMed Tervahauta M, Pekkanen J, Enlund H, Nissinen A. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens. 1994;12(10):1183–9.CrossRefPubMed
48.
go back to reference Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J, et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension. 2007;50(1):172–80.CrossRefPubMed Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J, et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension. 2007;50(1):172–80.CrossRefPubMed
49.
go back to reference Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. BMJ. 1988;296(6626):887–9.CrossRefPubMed Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. BMJ. 1988;296(6626):887–9.CrossRefPubMed
50.
go back to reference Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ. 1998;316(7147):1780–4.CrossRefPubMedPubMedCentral Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ. 1998;316(7147):1780–4.CrossRefPubMedPubMedCentral
51.
go back to reference Hakala SM, Tilvis RS, Strandberg TE. Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. Eur Heart J. 1997;18(6):1019–23. Hakala SM, Tilvis RS, Strandberg TE. Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. Eur Heart J. 1997;18(6):1019–23.
52.
go back to reference Le Couteur DG, Simpson SJ. Adaptive senectitude: the prolongevity effects of aging. J Gerontol A Biol Sci Med Sci. 2011;66(2):179–82.CrossRefPubMed Le Couteur DG, Simpson SJ. Adaptive senectitude: the prolongevity effects of aging. J Gerontol A Biol Sci Med Sci. 2011;66(2):179–82.CrossRefPubMed
53.
go back to reference Stessman J, Bursztyn M, Gershinsky Y, et al. Hypertension and its treatment at age 90 years: Is there an association with 5-year mortality? J Am Med Dir Assoc. 2017;18:277.e13e277.e19. Stessman J, Bursztyn M, Gershinsky Y, et al. Hypertension and its treatment at age 90 years: Is there an association with 5-year mortality? J Am Med Dir Assoc. 2017;18:277.e13e277.e19.
54.
go back to reference Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991;338(8778):1281–5. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991;338(8778):1281–5.
55.
go back to reference Amery A, Birkenhäger W, Brixko R, Bulpitt C, Clement D, Deruyttere M, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet. 1986;2(8507):589–92.CrossRefPubMed Amery A, Birkenhäger W, Brixko R, Bulpitt C, Clement D, Deruyttere M, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet. 1986;2(8507):589–92.CrossRefPubMed
56.
go back to reference Staessen JA, Fagard R, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med. 1998;158(15):1681–91.CrossRefPubMed Staessen JA, Fagard R, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med. 1998;158(15):1681–91.CrossRefPubMed
57.
go back to reference Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999;353(9155):793–6.CrossRefPubMed Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999;353(9155):793–6.CrossRefPubMed
58.
go back to reference Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, et al.; HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009–20. Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, et al.; HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009–20.
59.
go back to reference JATOS Study Group. Principal results of the Japanese Trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115–27.CrossRef JATOS Study Group. Principal results of the Japanese Trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115–27.CrossRef
60.
go back to reference Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al.; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56(2):196–202. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al.; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56(2):196–202.
61.
go back to reference Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al; SPS3 Study Group. Blood pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–515. Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al; SPS3 Study Group. Blood pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–515.
62.
go back to reference PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.CrossRef PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.CrossRef
63.
go back to reference Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA. 1997;278:212–6.PubMed Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA. 1997;278:212–6.PubMed
64.
go back to reference Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–51.CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–51.CrossRefPubMed
65.
go back to reference Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123(10):754–62. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123(10):754–62.
66.
go back to reference Hayashi K, Saruta T, Goto Y, et al. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hypertens Res. 2010;33:1211–20.CrossRefPubMed Hayashi K, Saruta T, Goto Y, et al. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hypertens Res. 2010;33:1211–20.CrossRefPubMed
67.
go back to reference Tsai WC, Wu HY, Peng YS, Yang JY, Chen HY, Chiu YL, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(6):792–9.CrossRefPubMedPubMedCentral Tsai WC, Wu HY, Peng YS, Yang JY, Chen HY, Chiu YL, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(6):792–9.CrossRefPubMedPubMedCentral
68.
go back to reference Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185:949–57.CrossRefPubMedPubMedCentral Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185:949–57.CrossRefPubMedPubMedCentral
70.
go back to reference Vetrano DL, Palmer KM, Galluzzo L, Giampaoli S, Marengoni A, Bernabei R, et al.; Joint Action ADVANTAGE WP4 group. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open. 2018;8(12):e024406. Vetrano DL, Palmer KM, Galluzzo L, Giampaoli S, Marengoni A, Bernabei R, et al.; Joint Action ADVANTAGE WP4 group. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open. 2018;8(12):e024406.
71.
go back to reference Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive imooact of antihypertensive treatment in very elderly people: an investigation of the imoact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.CrossRefPubMedPubMedCentral Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive imooact of antihypertensive treatment in very elderly people: an investigation of the imoact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.CrossRefPubMedPubMedCentral
72.
go back to reference Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomised trial. JAMA. 2016;315:2673–2682. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: a randomised trial. JAMA. 2016;315:2673–2682.
73.
go back to reference Ravindrarajah R, Hazra NC, Hamada S, Charlton J, Jackson SHD, Dregan A, et al. Systolic blood pressure trajectory, frailty, and all-cause mortality > 80 years of age: cohort study using electronic health records. Circulation. 2017;135(24):2357–68.CrossRefPubMedPubMedCentral Ravindrarajah R, Hazra NC, Hamada S, Charlton J, Jackson SHD, Dregan A, et al. Systolic blood pressure trajectory, frailty, and all-cause mortality > 80 years of age: cohort study using electronic health records. Circulation. 2017;135(24):2357–68.CrossRefPubMedPubMedCentral
74.
go back to reference Ogliari G, Sabayan B, Mari D, Rossi PD, Lucchi TA, de Craen AJ, Westendorp RG. Age- and functional status-dependent association between blood pressure and cognition: the Milan Geriatrics 75 + Cohort Study. J Am Geriatr Soc. 2015;63(9):1741–8.CrossRefPubMed Ogliari G, Sabayan B, Mari D, Rossi PD, Lucchi TA, de Craen AJ, Westendorp RG. Age- and functional status-dependent association between blood pressure and cognition: the Milan Geriatrics 75 + Cohort Study. J Am Geriatr Soc. 2015;63(9):1741–8.CrossRefPubMed
75.
go back to reference Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus study. J Am Geriatr Soc. 2012;60(11):2014–9.CrossRefPubMed Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus study. J Am Geriatr Soc. 2012;60(11):2014–9.CrossRefPubMed
76.
go back to reference Sabayan B, van Vliet P, de Ruijter W, Gussekloo J, de Craen AJ, Westendorp RG. High blood pressure, physical and cognitive function, and risk of stroke in the oldest old: the Leiden 85-plus study. Stroke. 2013;44(1):15–20.CrossRefPubMed Sabayan B, van Vliet P, de Ruijter W, Gussekloo J, de Craen AJ, Westendorp RG. High blood pressure, physical and cognitive function, and risk of stroke in the oldest old: the Leiden 85-plus study. Stroke. 2013;44(1):15–20.CrossRefPubMed
77.
go back to reference Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRefPubMed Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015;175(6):989–95.CrossRefPubMed
78.
go back to reference Odden MC, Beilby PR, Peralta CA. Blood pressure in older adults: the importance of frailty. Curr Hyperten Rep. 2015;17(7):55.CrossRef Odden MC, Beilby PR, Peralta CA. Blood pressure in older adults: the importance of frailty. Curr Hyperten Rep. 2015;17(7):55.CrossRef
79.
go back to reference Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M. Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med. 2015;277(4):488–97.CrossRefPubMed Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M. Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med. 2015;277(4):488–97.CrossRefPubMed
80.
go back to reference Peralta CA, Katz R, Newman AB, Psaty BM, Odden MC. Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study. Hypertension. 2014;64(3):472–80.CrossRefPubMedPubMedCentral Peralta CA, Katz R, Newman AB, Psaty BM, Odden MC. Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study. Hypertension. 2014;64(3):472–80.CrossRefPubMedPubMedCentral
81.
go back to reference Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension. 2014;63(3):433–41.CrossRefPubMed Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension. 2014;63(3):433–41.CrossRefPubMed
82.
go back to reference Bromfield SG, Ngameni CA, Colantonio LD, Bowling CB, Shimbo D, Reynolds K, et al. Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension. Hypertension. 2017;70(2):259–66.CrossRefPubMedPubMedCentral Bromfield SG, Ngameni CA, Colantonio LD, Bowling CB, Shimbo D, Reynolds K, et al. Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension. Hypertension. 2017;70(2):259–66.CrossRefPubMedPubMedCentral
83.
go back to reference Corrao G, Mazzola P, Monzio Compagnoni M, Rea F, Merlino L, Annoni G, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015;32(11):927–36.CrossRefPubMed Corrao G, Mazzola P, Monzio Compagnoni M, Rea F, Merlino L, Annoni G, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015;32(11):927–36.CrossRefPubMed
84.
go back to reference Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739–44.CrossRefPubMed Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739–44.CrossRefPubMed
85.
go back to reference Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep. 2017;19:24.CrossRefPubMedPubMedCentral Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep. 2017;19:24.CrossRefPubMedPubMedCentral
86.
go back to reference Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial. Am J Epidemiol. 2001;153:72e78. Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial. Am J Epidemiol. 2001;153:72e78.
87.
go back to reference Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–9.CrossRefPubMed Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–9.CrossRefPubMed
88.
go back to reference Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018;168(1):39–51.CrossRefPubMed Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018;168(1):39–51.CrossRefPubMed
89.
go back to reference van Middelaar T, van Vught LA, van Gool WA, et al. Blood pressure-lowering interventions to prevent dementia. J Hypertens. 2018;36:1780–7.CrossRefPubMed van Middelaar T, van Vught LA, van Gool WA, et al. Blood pressure-lowering interventions to prevent dementia. J Hypertens. 2018;36:1780–7.CrossRefPubMed
90.
go back to reference Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, et al; Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014;174:324–33. Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, et al; Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014;174:324–33.
91.
go back to reference Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, et al. SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561. Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, et al. SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561.
92.
go back to reference Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med. 2015;175(4):578–85.CrossRefPubMed Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med. 2015;175(4):578–85.CrossRefPubMed
93.
go back to reference Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy—the process of deprescribing. JAMA Intern Med. 2015;175:827–34.CrossRefPubMed Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy—the process of deprescribing. JAMA Intern Med. 2015;175:827–34.CrossRefPubMed
94.
go back to reference Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Ageing. 2008;25(12):1021–31.CrossRef Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Ageing. 2008;25(12):1021–31.CrossRef
95.
go back to reference van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J. Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017;35(9):1742–9.CrossRefPubMedPubMedCentral van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J. Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017;35(9):1742–9.CrossRefPubMedPubMedCentral
96.
go back to reference Gulla C, Flo E, Kjome RL, Husebo BS. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. J Geriatr Cardiol. 2018;15(4):275–83.PubMedPubMedCentral Gulla C, Flo E, Kjome RL, Husebo BS. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. J Geriatr Cardiol. 2018;15(4):275–83.PubMedPubMedCentral
97.
go back to reference Kostis JB, Espeland MA, Appel L, Johnson KC, Pierce J, Wofford JL. Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group. Am J Cardiol. 1998;82(12):1501–8.CrossRefPubMed Kostis JB, Espeland MA, Appel L, Johnson KC, Pierce J, Wofford JL. Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group. Am J Cardiol. 1998;82(12):1501–8.CrossRefPubMed
98.
go back to reference Ekbom T, Lindholm LH, Odén A, Dahlöf B, Hansson L, Wester PO, et al. A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly. J Intern Med. 1994;235(6):581–8.CrossRefPubMed Ekbom T, Lindholm LH, Odén A, Dahlöf B, Hansson L, Wester PO, et al. A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly. J Intern Med. 1994;235(6):581–8.CrossRefPubMed
99.
go back to reference Moonen JEF, Foster-Dingley JC, de Ruijter W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning. The DANTE Study Leiden. JAMA Intern Med. 2015;175:1622. Moonen JEF, Foster-Dingley JC, de Ruijter W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning. The DANTE Study Leiden. JAMA Intern Med. 2015;175:1622.
100.
go back to reference Bath PMW, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet. 2015;385:617–28.CrossRef Bath PMW, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet. 2015;385:617–28.CrossRef
101.
go back to reference Jongstra S, Harrison JK, Quinn TJ, Richard E. Antihypertensive withdrawal for the prevention of cognitive decline. Cochrane Database Syst Rev. 2016;11:CD011971. Jongstra S, Harrison JK, Quinn TJ, Richard E. Antihypertensive withdrawal for the prevention of cognitive decline. Cochrane Database Syst Rev. 2016;11:CD011971.
103.
go back to reference Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2016;4(12):e006544.CrossRef Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2016;4(12):e006544.CrossRef
104.
go back to reference Djatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? J Clin Pharm Ther. 2018;43(4):550–5.CrossRefPubMed Djatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? J Clin Pharm Ther. 2018;43(4):550–5.CrossRefPubMed
105.
go back to reference Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.CrossRefPubMed Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.CrossRefPubMed
106.
go back to reference Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–80.CrossRefPubMed Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–80.CrossRefPubMed
107.
go back to reference Hansen CR, O’Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, et al. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. J Clin Pharmacol. 2018;84(12):2716–28.CrossRef Hansen CR, O’Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, et al. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. J Clin Pharmacol. 2018;84(12):2716–28.CrossRef
Metadata
Title
Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients
Authors
Ian A. Scott
Sarah N. Hilmer
David G. Le Couteur
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 8/2019
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-019-00683-8

Other articles of this Issue 8/2019

Drugs & Aging 8/2019 Go to the issue